FDA Inspection 1029562 — Mary Greeley Medical Center IRB
The FDA completed an inspection of Mary Greeley Medical Center IRB on July 12, 2017 in Ames, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 12, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ames, IA (United States)
Additional Details
IRB